title: Defining optimal initial therapy for primary CNS lymphoma.
authors.affiliation: Neuro-Oncology Center, University of Virginia School of Medicine, Hospital West, Jefferson Park Avenue, Charlottesville, VA 22908-0432, USA. Electronic address: ds4jd@virginia.edu.
authors.forename: David
authors.initials: D
authors.lastname: Schiff
authors.affiliation: Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Havard T H Chan School of Public Health, Boston, MA, USA.
authors.forename: Fangxin
authors.initials: F
authors.lastname: Hong
authors.affiliation: Radiation Oncology, Dana-Farber Cancer Institute, Havard T H Chan School of Public Health, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
authors.forename: Brian
authors.initials: B
authors.lastname: Alexander
mesh_terms: D016543:Central Nervous System Neoplasms; D003561:Cytarabine; D006801:Humans; D008727:Methotrexate; D000069283:Rituximab; D013852:Thiotepa
chemical_list: D003561:Cytarabine; D000069283:Rituximab; D013852:Thiotepa; D008727:Methotrexate